LeConte Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$648K Buy
4,457
+168
+4% +$23.2K 0.35% 53
2026
Q2
$551K Buy
4,289
+755
+21% +$88.4K 0.3% 61
2026
Q1
$425K Buy
3,534
+447
+14% +$51.6K 0.27% 66
2025
Q4
$325K Buy
3,087
+309
+11% +$29K 0.21% 75
2025
Q3
$233K Buy
+2,778
New +$229K 0.16% 112

Other funds holding MRK

LeConte Wealth Management's MRK Position: Q3 2026 in Review

LeConte Wealth Management increased its Merck (MRK) stake by 3.9% in Q3 2026, buying an estimated $23.2K and bringing the position to 4,457 shares worth $648K. The position accounts for 0.35% of the portfolio, ranked #53.

LeConte Wealth Management first reported a position in MRK in Q3 2025 and has held it in 5 quarters since. 2,589 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • LeConte Wealth Management held 4,457 shares of Merck worth $648K as of Q3 2026.
  • LeConte Wealth Management bought 168 Merck shares in Q3 2026, an estimated $23.2K.
  • Merck made up 0.35% of LeConte Wealth Management's portfolio in Q3 2026, its #53 holding.
  • LeConte Wealth Management first reported a position in Merck in Q3 2025 and has held it in 5 quarters since.
  • 2,589 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on LeConte Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.